Business
AstraZeneca US COVID-19 vaccine trial may resume as soon as this week – Sydney Morning Herald
The pharma giant’s coronavirus vaccine trial in the United States is expected to resume as early as this week after the US Food and Drug Administration completed…
In a research and development briefing held for CSL investors on Tuesday, the company’s chief scientific officer Dr Andrew Nash said preparations to produce both vaccines were moving along well and production of the AstraZeneca product could start early next year.
He said the AstraZeneca/Oxford and University of Queensland projects used different approaches, with UQ’s being a more “classical” vaccine model while AstraZeneca’s was a newer approach, and it was a positive that both projects could be…
-
General23 hours agoSearch underway for missing boat off South Australia’s Cape Jaffa
-
Noosa News23 hours agoQueensland coroner investigates ‘extremely unusual’ deaths of premature twin boys
-
Noosa News9 hours agoThe Best Things to Do in Brisbane This New Year’s Eve
-
General8 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle